Carboplatin and gemcitabine in stage IV non small cell lung cancer: beyond cisplatin in palliative chemotherapy

被引：1
|
作者：
Tassinari, D
Fochessati, F
Arcangeli, V
Panzini, I
Ravaioli, A
Sartori, S
机构：
[1] City Hosp, Dept Oncol, I-47900 Rimini, Italy
[2] Arcispedale St Anna, Dept Internal Med, I-44100 Ferrara, Italy
来源：
LUNG CANCER | 2003年 / 39卷 / 01期
关键词：
D O I：
10.1016/S0169-5002(02)00386-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：107 / 108
页数：2
相关论文
共 50 条
  • [31] THE COMBINATION CHEMOTHERAPY OF GEMCITABINE, CARBOPLATIN AND BEVACIZUMAB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Kim, Bong Seog
    Ahn, Young Mi
    Lee, Moon Hyung
    Suh, Kang Heum
    Nam, Seung-Hyun
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1158 - S1158
  • [32] Gemcitabine and cisplatin combination in early-stage non-small-cell lung cancer
    Crinò, L
    Calandri, C
    Maestri, A
    Marrocolo, F
    ONCOLOGY-NEW YORK, 2001, 15 (03): : 40 - 42
  • [33] Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer
    Iaffaioli, RV
    Tortoriello, A
    Facchini, G
    Capenigro, F
    Gentile, M
    Marzano, N
    Gravina, A
    Dimitri, P
    Costagliola, G
    Ferraro, A
    Ferrante, G
    De Marino, V
    Illiano, A
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 921 - 926
  • [34] Comparative costs of gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of non-small cell lung cancer in Germany
    Bischoff, H
    Hamann, M
    Stynes, G
    Bhalla, S
    Tilden, D
    Kielhorn, A
    VALUE IN HEALTH, 2004, 7 (06) : 674 - 674
  • [35] Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: A phase III randomized study of the London Lung Cancer Group
    Rudd, RM
    Gower, NH
    Spiro, SG
    Eisen, TG
    Harper, PG
    Littler, JAH
    Hatton, M
    Johnson, PWM
    Martin, WMC
    Rankin, EM
    James, LE
    Gregory, WM
    Qian, W
    Lee, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 142 - 153
  • [36] Rational drug sequencing of paclitaxel, gemcitabine and carboplatin in patients with untreated stage IV and select stage IIIB non-small cell lung cancer
    Sovak, Mika A.
    Lutzker, Stuart
    Zheng, Ling
    Guensch, Lisa
    Joyce, Margaret
    Schwartz, Susan
    Wu, Yujun
    Aisner, Joseph
    LUNG CANCER, 2006, 53 (02) : 177 - 181
  • [37] Cisplatin or Carboplatin for Advanced Non-Small-Cell Lung Cancer?
    Sun, Xiaoli
    Zheng, Yulong
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : E70 - E70
  • [38] Maintenance chemotherapy with gemcitabine in patients pretreated with induction chemotherapy with cisplatin and gemcitabine for advanced non small cell lung cancer (A-NSCLC)
    Papi, Maximilian
    Nicoletti, Stefania
    Tassinari, Davide
    Tamburini, Emiliano
    Oliverio, Giovanni
    Agli, Luigi Lazzari
    Grani, Giorgio
    Salvi, Maurizio
    Pasquini, Enzo
    Ravaioli, Alberto
    ANNALS OF ONCOLOGY, 2007, 18 : 32 - 32
  • [39] An estimate of the cost effectiveness of gemcitabine in stage IV non-small cell lung cancer
    Evans, WK
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 82 - 89
  • [40] Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC)
    Garcia-Gomez, R
    Lopez-Criado, P
    Guevara, S
    Lahoz, C
    Chaib, C
    Gonzalez, C
    Santiago, J
    De Alvaro, J
    Carrion, R
    Perez-Manga, G
    ANNALS OF ONCOLOGY, 1998, 9 : 93 - 94
12345